synchrony financial - SYF
SYF
Close Chg Chg %
65.13 0.84 1.29%
Closed Market
65.97
+0.84 (1.29%)
Volume: 3.51M
Last Updated:
Nov 22, 2024, 3:59 PM EDT
Company Overview: synchrony financial - SYF
SYF Key Data
Open $65.06 | Day Range 65.04 - 66.25 |
52 Week Range 29.15 - 67.76 | Market Cap $25.36B |
Shares Outstanding 389.34M | Public Float 387.58M |
Beta 1.59 | Rev. Per Employee N/A |
P/E Ratio 8.50 | EPS $7.73 |
Yield 153.52% | Dividend $0.25 |
EX-DIVIDEND DATE Nov 4, 2024 | SHORT INTEREST N/A |
AVERAGE VOLUME 4.09M |
SYF Performance
1 Week | 1.55% | ||
1 Month | 19.66% | ||
3 Months | 35.78% | ||
1 Year | 121.22% | ||
5 Years | 78.83% |
SYF Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 63.15 | |
Number of Ratings | 22 | Current Quarters Estimate | 1.85 | |
FY Report Date | 12 / 2024 | Current Year's Estimate | 6.518 | |
Last Quarter’s Earnings | 1.94 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 5.19 | Next Fiscal Year Estimate | 6.435 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 19 | 16 | 15 | 20 |
Mean Estimate | 1.85 | 1.66 | 6.52 | 6.44 |
High Estimates | 2.00 | 2.09 | 6.93 | 7.50 |
Low Estimate | 1.30 | 1.18 | 6.20 | 5.19 |
Coefficient of Variance | 7.70 | 14.37 | 2.24 | 10.27 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 11 | 11 | 12 |
OVERWEIGHT | 1 | 1 | 1 |
HOLD | 9 | 10 | 10 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 1 | 1 | 1 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Synchrony Financial - SYF
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Synchrony Financial - SYF
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Aug 20, 2024 | Laurel J. Richie Director | 42,922 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 1,969,690.58 |
Aug 20, 2024 | Brian J. Wenzel See remarks | 76,251 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $46.73 per share | 3,563,209.23 |
Aug 20, 2024 | Darrell Owens See remarks | 20,829 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 955,842.81 |
Aug 20, 2024 | Bart Schaller See remarks | 49,659 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 2,278,851.51 |
Aug 20, 2024 | Curtis Howse See remarks | 121,677 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 5,583,757.53 |
Aug 20, 2024 | Brian J. Wenzel See remarks | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Aug 20, 2024 | Brian D. Doubles See remarks; Director | 659,652 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 30,271,430.28 |
Aug 20, 2024 | Brian J. Wenzel See remarks | 142,459 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 6,537,443.51 |
Aug 20, 2024 | Brian J. Wenzel See remarks | 150,949 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $29.33 per share | 4,427,334.17 |
Aug 20, 2024 | Alberto Casellas See remarks | 180 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Aug 20, 2024 | Jonathan S. Mothner See remarks | 145,358 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 6,670,478.62 |
Aug 20, 2024 | Roy A. Guthrie Director | 55,120 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 2,529,456.80 |
Aug 20, 2024 | Jeffrey G. Naylor Director | 81,351 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 3,733,197.39 |
Aug 20, 2024 | Ellen M. Zane Director | 25,693 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 1,179,051.77 |
Aug 20, 2024 | Arthur w Coviello Director | 46,008 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 2,111,307.12 |
Aug 20, 2024 | P. W. Parker Director | 27,939 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 1,282,120.71 |
Aug 20, 2024 | Kamila K. Chytil Director | 11,382 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 522,319.98 |
Aug 20, 2024 | Carol D. Juel See remarks | 66,620 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 3,057,191.80 |
Aug 20, 2024 | Alberto Casellas See remarks | 64,602 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 2,964,585.78 |
Aug 20, 2024 | Paget Leonard Alves Director | 42,945 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $45.89 per share | 1,970,746.05 |
Synchrony Financial in the News
Warren Buffett's Berkshire Hathaway shakes up investment holdings
Warren Buffett's Berkshire Hathaway cut back on financial, energy and drug stocks but beefed up its grocery and wireless holdings while adding an insurer.